Financials Sanifoam Sünger Sanayi ve Ticaret

Equities

SANFM

TRESNFM00016

Commodity Chemicals

Market Closed - Borsa Istanbul 16:08:03 23/05/2024 BST 5-day change 1st Jan Change
59.95 TRY +0.50% Intraday chart for Sanifoam Sünger Sanayi ve Ticaret -7.77% +53.25%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 16.5 66.01 179.5 407.4 606 1,174
Enterprise Value (EV) 1 40.56 98.16 216.7 444 691.5 1,404
P/E ratio 18.6 x 18.1 x 25.1 x 13.2 x 9.6 x 26.7 x
Yield - - - - 0.5% -
Capitalization / Revenue 0.2 x 0.7 x 1.64 x 2.82 x 1.93 x 1.66 x
EV / Revenue 0.49 x 1.05 x 1.98 x 3.07 x 2.21 x 1.99 x
EV / EBITDA 5.08 x 8.32 x 11.8 x 17.7 x 12 x 14.7 x
EV / FCF -30.4 x -257 x -354 x 83.9 x -13.8 x -25.8 x
FCF Yield -3.29% -0.39% -0.28% 1.19% -7.26% -3.88%
Price to Book 0.94 x 3.42 x 6.39 x 6.81 x 5.03 x 4.07 x
Nbr of stocks (in thousands) 30,000 30,000 30,000 30,000 30,000 30,000
Reference price 2 0.5501 2.200 5.985 13.58 20.20 39.12
Announcement Date 11/03/19 09/03/20 11/03/21 17/02/22 03/03/23 26/04/24
1TRY in Million2TRY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 82.17 93.87 109.4 144.5 313.6 706.3
EBITDA 1 7.99 11.79 18.4 25.06 57.55 95.28
EBIT 1 6.864 10.62 17.16 23.25 54.49 77.7
Operating Margin 8.35% 11.32% 15.69% 16.09% 17.38% 11%
Earnings before Tax (EBT) 1 1.232 5.039 8.381 36.31 74.48 44.12
Net income 1 0.8876 3.643 7.141 30.81 63.12 43.91
Net margin 1.08% 3.88% 6.53% 21.33% 20.13% 6.22%
EPS 2 0.0296 0.1214 0.2380 1.027 2.104 1.464
Free Cash Flow 1 -1.334 -0.3816 -0.6115 5.294 -50.24 -54.52
FCF margin -1.62% -0.41% -0.56% 3.66% -16.02% -7.72%
FCF Conversion (EBITDA) - - - 21.12% - -
FCF Conversion (Net income) - - - 17.18% - -
Dividend per Share - - - - 0.1000 -
Announcement Date 11/03/19 09/03/20 11/03/21 17/02/22 03/03/23 26/04/24
1TRY in Million2TRY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 24.1 32.2 37.1 36.6 85.5 231
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 3.011 x 2.726 x 2.019 x 1.46 x 1.486 x 2.42 x
Free Cash Flow 1 -1.33 -0.38 -0.61 5.29 -50.2 -54.5
ROE (net income / shareholders' equity) 5.51% 20% 29.9% 70.2% 69.6% 16.3%
ROA (Net income/ Total Assets) 6.16% 7.98% 9.56% 8.8% 12.3% 7.1%
Assets 1 14.42 45.67 74.69 350.3 514.2 618
Book Value Per Share 2 0.5800 0.6400 0.9400 2.000 4.010 9.600
Cash Flow per Share 2 0.0200 0.2000 1.040 1.380 1.300 0.8500
Capex 1 5.44 4.25 5.64 4.96 13.6 53
Capex / Sales 6.62% 4.52% 5.16% 3.43% 4.32% 7.5%
Announcement Date 11/03/19 09/03/20 11/03/21 17/02/22 03/03/23 26/04/24
1TRY in Million2TRY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. SANFM Stock
  4. Financials Sanifoam Sünger Sanayi ve Ticaret